Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination
COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk groups for vaccination given the limited supply of COVID-19 vaccines globally. Throughout 2020, CAVEI issued recommendations on the prioritization of population groups to be vaccinated against SARS-CoV-2 in response to different needs and in accordance with available evidence. These recommendations are consolidated in Table 1 in this report. In summary, it was recommended that healthcare workers, people in long-term residences and essential State personnel be vaccinated in phase 1. In phase 2, persons over 65 years of age and people with comorbidities. In phase 3, essential tasks workers and, lastly, the general population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia - 38(2021), 2 vom: 07. Apr., Seite 185-188 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Consolidado de recomendaciones del Comité Asesor de Vacunas y Estrategias de Inmunización-CAVEI, sobre priorización de vacunación COVID-19 |
|---|
| Beteiligte Personen: |
Dabanch, Jeannette [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.07.2021 Date Revised 02.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4067/S0716-10182021000200185 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327316594 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327316594 | ||
| 003 | DE-627 | ||
| 005 | 20231225200521.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.4067/S0716-10182021000200185 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1091.xml |
| 035 | |a (DE-627)NLM327316594 | ||
| 035 | |a (NLM)34184708 | ||
| 035 | |a (PII)S0716-10182021000200185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Dabanch, Jeannette |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination |
| 246 | 3 | 3 | |a Consolidado de recomendaciones del Comité Asesor de Vacunas y Estrategias de Inmunización-CAVEI, sobre priorización de vacunación COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.07.2021 | ||
| 500 | |a Date Revised 02.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk groups for vaccination given the limited supply of COVID-19 vaccines globally. Throughout 2020, CAVEI issued recommendations on the prioritization of population groups to be vaccinated against SARS-CoV-2 in response to different needs and in accordance with available evidence. These recommendations are consolidated in Table 1 in this report. In summary, it was recommended that healthcare workers, people in long-term residences and essential State personnel be vaccinated in phase 1. In phase 2, persons over 65 years of age and people with comorbidities. In phase 3, essential tasks workers and, lastly, the general population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Bastías, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Endeiza, María L |e verfasserin |4 aut | |
| 700 | 1 | |a Díaz, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Inostroza, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Cerda, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Santillana, Solange |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a González, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez, María |e verfasserin |4 aut | |
| 700 | 1 | |a Pizarro, Alejandra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia |d 1997 |g 38(2021), 2 vom: 07. Apr., Seite 185-188 |w (DE-627)NLM092581005 |x 0717-6341 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2021 |g number:2 |g day:07 |g month:04 |g pages:185-188 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4067/S0716-10182021000200185 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2021 |e 2 |b 07 |c 04 |h 185-188 | ||